UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Human regulatory T cells lack the cyclophosphamide‐extruding transporter ABCB1 and are more susceptible to cyclophosphamide‐induced apoptosis

European journal of immunology, 2014-12, Vol.44 (12), p.3614-3620

2014

Volltextzugriff (PDF)

Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303

Journal of clinical oncology, 2019-07, Vol.37 (21), p.1790-1799

2019

Volltextzugriff (PDF)

Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL

Cancer cell, 2021-12, Vol.39 (12), p.1643-1653.e3

2021

Volltextzugriff (PDF)

The effect of cyclophosphamide on the immune system: implications for clinical cancer therapy

Cancer Chemotherapy and Pharmacology, 2016-10, Vol.78 (4), p.661-671

2016

Volltextzugriff (PDF)

Immunotherapy of non-Hodgkin's lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor-modified T cells

Science translational medicine, 2016-09, Vol.8 (355), p.355ra116

2016

Volltextzugriff (PDF)

TBCRC 031: Randomized Phase II Study of Neoadjuvant Cisplatin Versus Doxorubicin-Cyclophosphamide in Germline BRCA Carriers With HER2-Negative Breast Cancer (the INFORM trial)

Journal of clinical oncology, 2020-05, Vol.38 (14), p.1539-1548

2020

Volltextzugriff (PDF)

Neoadjuvant chemotherapy induces breast cancer metastasis through a TMEM-mediated mechanism

Science translational medicine, 2017-07, Vol.9 (397)

2017

Volltextzugriff (PDF)

Cyclophosphamide and cancer: golden anniversary

Nature reviews. Clinical oncology, 2009-11, Vol.6 (11), p.638-647

2009

Volltextzugriff (PDF)

Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival

Nature medicine, 2012-08, Vol.18 (8), p.1254-1261

2012

Volltextzugriff (PDF)

Phase III Trial Adding Vincristine-Topotecan-Cyclophosphamide to the Initial Treatment of Patients With Nonmetastatic Ewing Sarcoma: A Children's Oncology Group Report

Journal of clinical oncology, 2021-12, Vol.39 (36), p.4029-4038

2021

Volltextzugriff (PDF)

Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance

Nature (London), 2015-11, Vol.527 (7579), p.472-476

2015

Volltextzugriff (PDF)

FDA Approval Summary: Axicabtagene Ciloleucel for Relapsed or Refractory Large B-cell Lymphoma

Clinical cancer research, 2019-03, Vol.25 (6), p.1702-1708

2019

Volltextzugriff (PDF)

Low dose cyclophosphamide: Mechanisms of T cell modulation

Cancer treatment reviews, 2016-01, Vol.42, p.3-9

2016

Volltextzugriff (PDF)

B Cell Abnormalities in Systemic Lupus Erythematosus and Lupus Nephritis-Role in Pathogenesis and Effect of Immunosuppressive Treatments

International journal of molecular sciences, 2019-12, Vol.20 (24), p.6231

2019

Volltextzugriff (PDF)

Cyclophosphamide bioactivation pharmacogenetics in breast cancer patients

Cancer chemotherapy and pharmacology, 2021-09, Vol.88 (3), p.533-542

2021

Volltextzugriff (PDF)

The dual roles of ginsenosides in improving the anti-tumor efficiency of cyclophosphamide in mammary carcinoma mice

Journal of ethnopharmacology, 2021-01, Vol.265, p.113271, Article 113271

2021

Volltextzugriff (PDF)

Doxycycline Combined With Bortezomib-Cyclophosphamide-Dexamethasone Chemotherapy for Newly Diagnosed Cardiac Light-Chain Amyloidosis: A Multicenter Randomized Controlled Trial

Circulation (New York, N.Y.), 2022-01, Vol.145 (1), p.8-17

2022

Volltextzugriff (PDF)

Effects of chemotherapeutic agents on male germ cells and possible ameliorating impact of antioxidants

Biomedicine & pharmacotherapy, 2021-10, Vol.142, p.112040, Article 112040

2021

Volltextzugriff (PDF)

Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203)

The Lancet. Haematology, 2019-03, Vol.6 (3), p.e132-e143

2019

Volltextzugriff (PDF)

Aldehyde dehydrogenase expression drives human regulatory T cell resistance to posttransplantation cyclophosphamide

Science translational medicine, 2013-11, Vol.5 (211), p.211ra157

2013

Volltextzugriff (PDF)

Regulatory T-cell Modulation Using Cyclophosphamide in Vaccine Approaches: A Current Perspective

Cancer research (Chicago, Ill.), 2012-07, Vol.72 (14), p.3439-3444

2012

Volltextzugriff (PDF)

The magnitude of gonadotoxicity of chemotherapy drugs on ovarian follicles and granulosa cells varies depending upon the category of the drugs and the type of granulosa cells

Human reproduction (Oxford), 2015-12, Vol.30 (12), p.2926-2935

2015

Volltextzugriff (PDF)

CCR2 Influences T Regulatory Cell Migration to Tumors and Serves as a Biomarker of Cyclophosphamide Sensitivity

Cancer research (Chicago, Ill.), 2016-11, Vol.76 (22), p.6483-6494

2016

Volltextzugriff (PDF)

Inhibition of the cation channel TRPV4 improves bladder function in mice and rats with cyclophosphamide-induced cystitis

Proceedings of the National Academy of Sciences - PNAS, 2010-11, Vol.107 (44), p.19084-19089

2010

Volltextzugriff (PDF)

Myeloablative and reduced-intensity conditioning in HLA-haploidentical peripheral blood stem cell transplantation using post-transplant cyclophosphamide

Bone marrow transplantation (Basingstoke), 2019-03, Vol.54 (3), p.432-441

2019

Volltextzugriff (PDF)

1 – 25 von 16.541

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(13.932)
Mit Volltextzugriff
(11.442)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(12.674)
Life Sciences & Biomedicine
(12.397)
Animals
(8.946)
Humans
(8.352)
Female
(7.931)
Biological And Medical Sciences
(7.634)
Medical Sciences
(7.218)
Cyclophosphamide - Pharmacology
(7.073)
Male
(6.791)
Pharmacology. Drug Treatments
(6.251)
Mice
(5.584)
Oncology
(4.950)
Cyclophosphamide - Administration & Dosage
(4.619)
Cyclophosphamide
(4.322)
Antineoplastic Agents
(4.067)
Middle Aged
(3.834)
Adult
(3.662)
Chemotherapy
(3.439)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(3.361)
Pharmacology & Pharmacy
(2.972)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(16.071)
EZB Electronic Journals Library
(6.945)
Ovid SocietyJournals and Single Titles
(6.268)
Ingenta
(6.073)
NUS Single-Journal Subscriptions
(3.715)
Elsevier ScienceDirect Journals Complete
(2.547)
IngentaConnect Journals
(2.488)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(2.405)
Wiley Online Library Journals
(2.229)
Wiley Online Library Full Collection 2018
(1.886)
Springer journals
(1.743)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(1.355)
Nature Journals
(862)
Nexis Uni
(643)
Taylor & Francis Journals Auto-Holdings Collection
(571)
Oxford journals
(551)
Taylor & Francis
(549)
Taylor & Francis Current Content Access
(546)
SpringerLink Series
(494)
Oxford Journals 2020 Medicine
(361)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cancer Research
(433)
Bone Marrow Transplantation
(383)
Journal Of Clinical Oncology
(377)
Annals Of Oncology
(346)
Cancer
(319)
Cancer Chemotherapy And Pharmacology
(314)
Blood
(244)
Mutation Research
(239)
The Journal Of Immunology
(207)
British Journal Of Cancer
(202)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(35)
... seit 30 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Human regulatory T cells lack the cyclophosphamide‐extruding transporter ABCB1 and are more susceptible to cyclophosphamide‐induced apoptosis

Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303

Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL

The effect of cyclophosphamide on the immune system: implications for clinical cancer therapy

Immunotherapy of non-Hodgkin's lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor-modified T cells

TBCRC 031: Randomized Phase II Study of Neoadjuvant Cisplatin Versus Doxorubicin-Cyclophosphamide in Germline BRCA Carriers With HER2-Negative Breast Cancer (the INFORM trial)

Neoadjuvant chemotherapy induces breast cancer metastasis through a TMEM-mediated mechanism

Cyclophosphamide and cancer: golden anniversary

Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival

Phase III Trial Adding Vincristine-Topotecan-Cyclophosphamide to the Initial Treatment of Patients With Nonmetastatic Ewing Sarcoma: A Children's Oncology Group Report

Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance

FDA Approval Summary: Axicabtagene Ciloleucel for Relapsed or Refractory Large B-cell Lymphoma

Low dose cyclophosphamide: Mechanisms of T cell modulation

B Cell Abnormalities in Systemic Lupus Erythematosus and Lupus Nephritis-Role in Pathogenesis and Effect of Immunosuppressive Treatments

Cyclophosphamide bioactivation pharmacogenetics in breast cancer patients

The dual roles of ginsenosides in improving the anti-tumor efficiency of cyclophosphamide in mammary carcinoma mice

Doxycycline Combined With Bortezomib-Cyclophosphamide-Dexamethasone Chemotherapy for Newly Diagnosed Cardiac Light-Chain Amyloidosis: A Multicenter Randomized Controlled Trial

Effects of chemotherapeutic agents on male germ cells and possible ameliorating impact of antioxidants

Aldehyde dehydrogenase expression drives human regulatory T cell resistance to posttransplantation cyclophosphamide

Regulatory T-cell Modulation Using Cyclophosphamide in Vaccine Approaches: A Current Perspective

The magnitude of gonadotoxicity of chemotherapy drugs on ovarian follicles and granulosa cells varies depending upon the category of the drugs and the type of granulosa cells

CCR2 Influences T Regulatory Cell Migration to Tumors and Serves as a Biomarker of Cyclophosphamide Sensitivity

Inhibition of the cation channel TRPV4 improves bladder function in mice and rats with cyclophosphamide-induced cystitis

Myeloablative and reduced-intensity conditioning in HLA-haploidentical peripheral blood stem cell transplantation using post-transplant cyclophosphamide

Suchergebnisse filtern